Authors

• Yifan Shi (ORCID: https://orcid.org/0000-0002-1164-2469)
• Renhua Lu (ORCID: https://orcid.org/0000-0003-3555-505X)
• Zhaohui Ni (ORCID: https://orcid.org/0000-0002-1334-7658)
• Xinzhou Zhang (ORCID: https://orcid.org/0000-0003-1082-2625)
• Qinkai Chen (ORCID: https://orcid.org/0000-0002-0375-2860)
• Guojian Shao (ORCID: https://orcid.org/0000-0003-3433-2946)
• Haijiao Jin (ORCID: https://orcid.org/0000-0003-2804-4702)
• Yuqing Ren (ORCID: https://orcid.org/0000-0003-2750-2011)
• Weimin Yu (ORCID: https://orcid.org/0000-0002-5590-6542)
• Hui Peng
• Yao Li (ORCID: https://orcid.org/0000-0002-7872-1495)
• Qinghong Zhang (ORCID: https://orcid.org/0000-0002-1475-0860)
• Lihong Zhang (ORCID: https://orcid.org/0000-0003-2738-6268)
• Li Zuo (ORCID: https://orcid.org/0000-0002-3668-004X)
• Qun Luo (ORCID: https://orcid.org/0000-0001-7498-5883)
• Qiong Yang (ORCID: https://orcid.org/0000-0002-3658-1375)
• Jie Xiao (ORCID: https://orcid.org/0009-0002-2261-5682)
• Shuguang Qin (ORCID: https://orcid.org/0000-0002-3032-3869)

Institutions

• Hebei Medical University (CN)
• Nanchang University (CN)
• Sun Yat-sen University (CN)
• Shanghai Jiao Tong University (CN)
• Peking University (CN)
• Renji Hospital (CN)
• Sun Yat-sen Memorial Hospital (CN)
• First Affiliated Hospital of Guangzhou Medical University (CN)
• Wenzhou Central Hospital (CN)
• ShenZhen People’s Hospital (CN)
• AstraZeneca (France) (FR)
• Guangzhou First People's Hospital (CN)
• Taihe Hospital (CN)
• Peking University People's Hospital (CN)
• AstraZeneca (Poland) (PL)
• First Hospital of China Medical University (CN)
• Third Affiliated Hospital of Sun Yat-sen University (CN)
• China Coal Technology and Engineering Group Corp (China) (CN)
• First Affiliated Hospital of Hebei Medical University (CN)
• Shanxi Academy of Medical Sciences (CN)
• First Affiliated Hospital of Nanchang University (CN)
• University of Chinese Academy of Sciences (CN)
• China Medical University (CN)
• Guangzhou Medical University (CN)

Publication Details

Journal

Renal Failure

Published

2024-09-09

DOI

https://doi.org/10.1080/0886022x.2024.2384585

Citations

2

Primary Topic

Potassium and Related Disorders

Type

article

Field-Weighted Citation Impact

0.84

Funders

• AstraZeneca
• National Natural Science Foundation of China
• Shanghai Jiao Tong University
• Shanghai Hospital Development Center
• School of Medicine, Shanghai Jiao Tong University